01 1Polypeptide Laboratories San Diego, LLC
01 1MOTIXAFORTIDE
01 1Blank
NDC Package Code : 58862-0177
Start Marketing Date : 2023-09-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
20
PharmaCompass offers a list of Motixafortide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Motixafortide manufacturer or Motixafortide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Motixafortide manufacturer or Motixafortide supplier.
PharmaCompass also assists you with knowing the Motixafortide API Price utilized in the formulation of products. Motixafortide API Price is not always fixed or binding as the Motixafortide Price is obtained through a variety of data sources. The Motixafortide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Motixafortide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Motixafortide, including repackagers and relabelers. The FDA regulates Motixafortide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Motixafortide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Motixafortide supplier is an individual or a company that provides Motixafortide active pharmaceutical ingredient (API) or Motixafortide finished formulations upon request. The Motixafortide suppliers may include Motixafortide API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Motixafortide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Motixafortide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Motixafortide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Motixafortide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Motixafortide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Motixafortide suppliers with NDC on PharmaCompass.
